Meta-analysis of medical management versus catheter ablation for atrial fibrillation
Several observational studies have shown a survival benefit for patients with atrial fibrillation (AF) who are treated with catheter ablation (CA) rather than medical management (MM). However, data from randomized controlled trials (RCTs) are uncertain. Therefore, we performed a meta-analysis of RCT...
Main Author: | Yin-jun Mao, Hang Wang, Jian-xing Chen, Pin-fang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2020-09-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://rcm.imrpress.com/fileup/2153-8174/PDF/1601433279773-1473866977.pdf |
Similar Items
-
Catheter Ablation for Atrial Fibrillation
by: Andre J. Gauri, et al.
Published: (2003-10-01) -
Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
by: Sergio Conti, et al.
Published: (2023-09-01) -
Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
by: Giuseppe Nasso, et al.
Published: (2021-06-01) -
Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
by: John Marcus Wharton, et al.
Published: (2022-02-01) -
Risk and Protective Factors of Recurrence after Catheter Ablation for Atrial Fibrillation
by: Xinwei Guo, et al.
Published: (2024-03-01)